AI could offer more precise breast cancer recurrence risk, study finds
medicalnewstoday.comMedicalNewsToday
A new study demonstrates that AI can predict breast cancer recurrence risk with greater accuracy, particularly for outcomes occurring five or more years after initial treatment. The research suggests AI-based models may improve clinical decision-making for patient monitoring and follow-up care.
Why it mattersFor healthcare professionals reading AI Tools Daily, this shows a concrete clinical application where AI outperforms traditional risk assessment, potentially enabling more personalized treatment strategies and reducing unnecessary interventions for low-risk patients.
Read at medicalnewstoday.com